These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3114201)

  • 1. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.
    Tatsumi K; Fukushima M; Shirasaka T; Fujii S
    Jpn J Cancer Res; 1987 Jul; 78(7):748-55. PubMed ID: 3114201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
    Tuchman M; Ramnaraine ML; O'Dea RF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
    Ho DH; Townsend L; Luna MA; Bodey GP
    Anticancer Res; 1986; 6(4):781-4. PubMed ID: 3752956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase.
    Tatsumi K; Yamauchi T; Kiyono K; Kishi K; Yanagihara Y; Imaoka T; Kawaguchi T; Kubo M
    J Biochem; 1993 Dec; 114(6):912-8. PubMed ID: 8138551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BOF-A1 and BOF-A2, new 5-FU degradation-inhibitory agents].
    Fujii S
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2244-50. PubMed ID: 2955745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
    Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
    Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose, administration time and route and hepatic function-dependent metabolism of 5-FU in mice].
    Okamoto M; Takao A; Fujita H
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3483-90. PubMed ID: 3789759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction.
    Stopper H; Kühnel A; Podschun B
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1124-30. PubMed ID: 8093030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assay method for uracil, dihydrouracil, 5-fluorouracil and 5-fluoro-5, 6-dihydrouracil by high-performance liquid chromatography].
    Nakamura A; Kikuchi K; Ohishi T; Masuike T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):381-6. PubMed ID: 15045945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo 19F magnetic resonance spectroscopic observation.
    Harada M; Nishitani H; Koga K; Miura I; Kimura A
    Jpn J Cancer Res; 1993 Feb; 84(2):197-202. PubMed ID: 8463136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymes of uracil catabolism in normal and neoplastic human tissues.
    Naguib FN; el Kouni MH; Cha S
    Cancer Res; 1985 Nov; 45(11 Pt 1):5405-12. PubMed ID: 3931905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
    Naguib FN; Hao SN; el Kouni MH
    Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of natural pyrimidines and of certain related compounds on the spontaneous activity of the mouse.
    Krooth RS; Hsiao WL; Lam GF
    J Pharmacol Exp Ther; 1978 Nov; 207(2):504-14. PubMed ID: 712633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pyrimidine nucleoside phosphorylase inhibitors on hepatic fluoropyrimidine elimination in the rat.
    LaCreta FP; Warren BS; Williams WM
    Cancer Res; 1989 May; 49(10):2567-73. PubMed ID: 2523758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro degradation of pyrimidine bases: studies of rat liver dihydropyrimidine dehydrogenase.
    Tuchman M; Ramnaraine ML; O'Dea RF
    Adv Exp Med Biol; 1986; 195 Pt B():245-8. PubMed ID: 3766229
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of 5-diazouracil on the catabolism of circulating pyrimidines in rat liver and kidneys.
    Holstege A; Pausch J; Gerok W
    Cancer Res; 1986 Nov; 46(11):5576-81. PubMed ID: 3756903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase.
    Goudgaon NM; Naguib FN; el Kouni MH; Schinazi RF
    J Med Chem; 1993 Dec; 36(26):4250-4. PubMed ID: 8277507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
    Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
    Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.